1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
69324A3DD18C9BA0185256C7C007B9AF9
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/can-pharmaceutical-diagnostic-companies-work-together-case-studies?opendocument
18
19opendocument
2034.236.145.124
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Business Operations Alliances and Partnerships

Can Pharmaceutical & Diagnostic Companies Work Together?: Case Studies

DB Image

ID: 4358


Features:

Graphics


Words: 3,000


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This 9-page document describes two partnerships between a pharmaceutical and diagnostic companies. The first study profiles the timeline of the development of statins, Merck's launch of its first statin and the corresponding testing market that emerged for cholesterol markers. The second profile looks at one pharmaceutical companies' launch of an anti-viral and its search through three partnerships for a test to complement is therapeutic. Factors for the success and failure of this type of partnership are described.

Industries Profiled:
Pharmaceutical; Health Care


Companies Profiled:
Merck


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.